• 1. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 2. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

Professional Introduction to 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene (CAS No. 886500-93-2)

4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene, identified by its CAS number 886500-93-2, is a versatile aromatic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural features, serves as a crucial intermediate in the synthesis of various biologically active molecules. The presence of both bromomethyl and chloro substituents, along with the trifluoromethoxy group, makes it a valuable building block for medicinal chemists and researchers exploring novel therapeutic agents.

The bromomethyl moiety in 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene is particularly noteworthy due to its reactivity. This group readily participates in nucleophilic substitution reactions, enabling the facile introduction of diverse functional groups. Such reactivity is exploited in the synthesis of complex molecules, including those with potential pharmaceutical applications. The chloro substituent further enhances the compound's utility by providing another site for functionalization, allowing for the construction of polycyclic structures and heterocycles.

The trifluoromethoxy group is another key feature of this compound, contributing to its electronic properties and influencing its interactions with biological targets. Trifluoromethoxy-substituted aromatic compounds are known for their enhanced metabolic stability and improved binding affinity to certain enzymes and receptors. This makes 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene a promising candidate for drug discovery efforts aimed at developing new treatments for various diseases.

In recent years, there has been a surge in research focused on the development of small-molecule inhibitors targeting protein-protein interactions (PPIs). These interactions are critical in many biological processes and are often implicated in diseases such as cancer and inflammation. The structural features of 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene make it an attractive scaffold for designing PPI inhibitors. For instance, the bromomethyl group can be used to introduce linkers or other pharmacophores that disrupt specific PPIs, while the chloro and trifluoromethoxy groups can be tailored to optimize binding interactions.

The compound has also been explored in the synthesis of kinase inhibitors, which are another major class of therapeutic agents. Kinases play a central role in signal transduction pathways and are frequently dysregulated in diseases such as cancer. By leveraging the reactivity of the bromomethyl and chloro groups, researchers have been able to develop novel kinase inhibitors based on 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene. These inhibitors have shown promise in preclinical studies, highlighting the compound's potential as a drug development intermediate.

The trifluoromethoxy group has been particularly influential in enhancing the potency and selectivity of kinase inhibitors derived from this scaffold. The electron-withdrawing nature of fluorine atoms increases the lipophilicity of the molecule, improving its ability to cross cell membranes and reach target kinases. Additionally, fluorine atoms can modulate hydrogen bonding interactions, leading to more favorable binding affinities. These properties have made trifluoromethoxy-substituted compounds valuable tools in medicinal chemistry.

In addition to its applications in drug discovery, 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene has found utility in materials science. Its unique electronic properties make it a suitable candidate for use in organic electronics, such as organic light-emitting diodes (OLEDs) and organic photovoltaics (OPVs). The presence of both bromomethyl and chloro groups allows for further functionalization, enabling the tuning of optoelectronic properties for specific applications.

The synthesis of 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene typically involves multi-step reactions starting from commercially available aromatic precursors. Common synthetic routes include halogenation reactions followed by selective substitution with bromine or chlorine reagents. The trifluoromethoxy group is introduced through nucleophilic aromatic substitution or metal-catalyzed cross-coupling reactions. These synthetic strategies highlight the compound's accessibility and versatility as a synthetic intermediate.

The growing interest in fluorinated compounds has driven innovation in synthetic methodologies for introducing fluorine atoms into organic molecules. Techniques such as electrophilic aromatic substitution and transition-metal-catalyzed reactions have been refined to achieve high selectivity and yield when incorporating trifluoromethoxy groups. These advancements have made it easier to access complex fluorinated derivatives of 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene, expanding its utility in various fields.

In conclusion, 4-(Bromomethyl)-1-chloro-2-(trifluoromethoxy)benzene (CAS No. 886500-93-2) is a multifaceted compound with significant potential in pharmaceutical research and materials science. Its unique structural features enable diverse functionalization strategies, making it a valuable intermediate for synthesizing biologically active molecules and advanced materials. The continued exploration of this compound will likely lead to new discoveries and applications across multiple scientific disciplines.

• 1350760-79-0(1,3-Dichloro-5-methyl-2-(trifluoromethoxy)benzene)
• 1225665-64-4(1-chloro-2-(difluoromethoxy)-4-methylbenzene)
• 1261762-32-6(2-(Bromomethyl)-1-chloro-4-(trifluoromethoxy)benzene)
• 75462-60-1(2-Chloro-4-methyl-1-(trifluoromethoxy)benzene)
• 886499-59-8(4-chloro-3-(trifluoromethoxy)benzaldehyde)
• 261763-18-2(4-(Bromomethyl)-2-chloro-1-(trifluoromethoxy)benzene)
• 58215-11-5(4-(Bromomethyl)-2-chloro-1-(difluoromethoxy)benzene)
• 1350760-81-4(1,3-Dichloro-5-(dibromomethyl)-2-(trifluoromethoxy)benzene)
• 1706435-11-1(3,4-Dichloro-5-(trifluoromethoxy)benzyl bromide)
• 886503-33-9(3-CHLORO-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE)